25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Harrow Health Inc
Buy, Hold or Sell?

Let's analyze Harrow together

I guess you are interested in Harrow Health Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Harrow Health Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Harrow Health Inc

I send you an email if I find something interesting about Harrow Health Inc.

1. Quick Overview

1.1. Quick analysis of Harrow (30 sec.)










1.2. What can you expect buying and holding a share of Harrow? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
27.5%

What is your share worth?

Current worth
$1.61
Expected worth in 1 year
$1.11
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-0.50
Return On Investment
-1.5%

For what price can you sell your share?

Current Price per Share
$33.46
Expected price per share
$26.21 - $43.59
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Harrow (5 min.)




Live pricePrice per Share (EOD)
$33.46
Intrinsic Value Per Share
$-11.59 - $2.03
Total Value Per Share
$-9.98 - $3.65

2.2. Growth of Harrow (5 min.)




Is Harrow growing?

Current yearPrevious yearGrowGrow %
How rich?$57.6m$36.4m$24.9m40.6%

How much money is Harrow making?

Current yearPrevious yearGrowGrow %
Making money-$8.3m-$3.5m-$4.7m-57.5%
Net Profit Margin-21.5%-11.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Harrow (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Harrow?

Welcome investor! Harrow's management wants to use your money to grow the business. In return you get a share of Harrow.

First you should know what it really means to hold a share of Harrow. And how you can make/lose money.

Speculation

The Price per Share of Harrow is $33.46. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Harrow.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Harrow, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.61. Based on the TTM, the Book Value Change Per Share is $-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $0.52 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Harrow.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.12-0.4%-0.23-0.7%-0.10-0.3%-0.12-0.3%-0.08-0.3%
Usd Book Value Change Per Share-0.02-0.1%-0.13-0.4%0.521.6%0.050.1%0.030.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-0.1%-0.13-0.4%0.531.6%0.050.1%0.040.1%
Usd Price Per Share44.96-22.57-17.33-12.44-8.56-
Price to Earnings Ratio-95.09--35.85-6.75--2.65--5.17-
Price-to-Total Gains Ratio-2,319.85--728.53-292.08--68.14--62.75-
Price to Book Ratio27.86-13.56-23.02-41.88-47.67-
Price-to-Total Gains Ratio-2,319.85--728.53-292.08--68.14--62.75-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share33.46
Number of shares29
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.130.05
Usd Total Gains Per Share-0.130.05
Gains per Quarter (29 shares)-3.651.42
Gains per Year (29 shares)-14.595.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-15-2505-4
20-29-400112
30-44-550168
40-58-7012214
50-73-8512720
60-88-10013326
70-102-11513832
80-117-13014438
90-131-14514944
100-146-16025550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%9.031.00.022.5%9.065.00.012.2%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%8.012.00.040.0%15.025.00.037.5%23.050.01.031.1%
Dividend per Share0.00.04.00.0%2.00.010.016.7%7.00.013.035.0%11.00.029.027.5%14.00.060.018.9%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%8.012.00.040.0%15.025.00.037.5%23.050.01.031.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Harrow Health Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.019-0.126+549%0.523-104%0.047-141%0.033-158%
Book Value Per Share--1.6141.723-6%1.024+58%0.835+93%0.552+192%
Current Ratio--1.5482.491-38%4.420-65%4.367-65%3.333-54%
Debt To Asset Ratio--0.8360.805+4%0.842-1%0.773+8%0.740+13%
Debt To Equity Ratio--5.0704.167+22%6.458-21%8.671-42%12.178-58%
Dividend Per Share----0%0.004-100%0.001-100%0.003-100%
Enterprise Value--1383853912.000625542615.633+121%483585287.750+186%370440842.677+274%264004939.238+424%
Eps---0.118-0.234+98%-0.100-16%-0.115-3%-0.084-29%
Ev To Ebitda Ratio--74.06618.061+310%38.910+90%561.634-87%315.789-77%
Ev To Sales Ratio--7.0243.455+103%4.494+56%3.885+81%9.484-26%
Free Cash Flow Per Share--0.0680.021+220%-1.172+1823%-0.260+482%-0.162+338%
Free Cash Flow To Equity Per Share--0.0480.011+339%0.103-53%0.144-67%0.070-32%
Gross Profit Margin--1.0001.0000%1.0000%0.678+48%0.945+6%
Intrinsic Value_10Y_max--2.035--------
Intrinsic Value_10Y_min---11.591--------
Intrinsic Value_1Y_max---0.526--------
Intrinsic Value_1Y_min---1.673--------
Intrinsic Value_3Y_max---1.023--------
Intrinsic Value_3Y_min---4.613--------
Intrinsic Value_5Y_max---0.851--------
Intrinsic Value_5Y_min---7.078--------
Market Cap1191667862.000-35%1605170912.000804829615.633+99%617291787.750+160%443265842.677+262%304811053.188+427%
Net Profit Margin---0.086-0.215+151%-0.114+33%-0.157+83%-0.489+471%
Operating Margin--0.027-0.085+417%-0.041+253%-0.073+371%-0.453+1785%
Operating Ratio--0.9731.066-9%0.980-1%0.996-2%1.425-32%
Pb Ratio20.732-34%27.85713.558+105%23.024+21%41.877-33%47.671-42%
Pe Ratio-70.770+26%-95.093-35.854-62%6.745-1510%-2.645-97%-5.166-95%
Price Per Share33.460-34%44.96022.570+99%17.333+159%12.441+261%8.556+425%
Price To Free Cash Flow Ratio123.002-34%165.27723.290+610%7.569+2084%7.564+2085%-8.161+105%
Price To Total Gains Ratio-1726.470+26%-2319.848-728.528-69%292.077-894%-68.140-97%-62.754-97%
Quick Ratio--1.3302.237-41%3.743-64%4.732-72%3.540-62%
Return On Assets---0.012-0.027+126%-0.015+21%-0.028+135%-0.079+554%
Return On Equity---0.073-0.135+85%-0.130+79%-0.466+540%-1.533+2006%
Total Gains Per Share---0.019-0.126+549%0.527-104%0.049-140%0.036-154%
Usd Book Value--57621000.00061384500.000-6%36466750.000+58%29743900.000+94%19677279.350+193%
Usd Book Value Change Per Share---0.019-0.126+549%0.523-104%0.047-141%0.033-158%
Usd Book Value Per Share--1.6141.723-6%1.024+58%0.835+93%0.552+192%
Usd Dividend Per Share----0%0.004-100%0.001-100%0.003-100%
Usd Enterprise Value--1383853912.000625542615.633+121%483585287.750+186%370440842.677+274%264004939.238+424%
Usd Eps---0.118-0.234+98%-0.100-16%-0.115-3%-0.084-29%
Usd Free Cash Flow--2428000.000757500.000+221%-41738250.000+1819%-9254250.000+481%-5771461.250+338%
Usd Free Cash Flow Per Share--0.0680.021+220%-1.172+1823%-0.260+482%-0.162+338%
Usd Free Cash Flow To Equity Per Share--0.0480.011+339%0.103-53%0.144-67%0.070-32%
Usd Market Cap1191667862.000-35%1605170912.000804829615.633+99%617291787.750+160%443265842.677+262%304811053.188+427%
Usd Price Per Share33.460-34%44.96022.570+99%17.333+159%12.441+261%8.556+425%
Usd Profit---4220000.000-8351500.000+98%-3552000.000-16%-4066150.000-4%-2972582.000-30%
Usd Revenue--49257000.00042284500.000+16%28541750.000+73%24276100.000+103%15560927.625+217%
Usd Total Gains Per Share---0.019-0.126+549%0.527-104%0.049-140%0.036-154%
 EOD+4 -4MRQTTM+26 -11YOY+22 -175Y+22 -1810Y+21 -19

3.3 Fundamental Score

Let's check the fundamental score of Harrow Health Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-70.770
Price to Book Ratio (EOD)Between0-120.732
Net Profit Margin (MRQ)Greater than0-0.086
Operating Margin (MRQ)Greater than00.027
Quick Ratio (MRQ)Greater than11.330
Current Ratio (MRQ)Greater than11.548
Debt to Asset Ratio (MRQ)Less than10.836
Debt to Equity Ratio (MRQ)Less than15.070
Return on Equity (MRQ)Greater than0.15-0.073
Return on Assets (MRQ)Greater than0.05-0.012
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Harrow Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.844
Ma 20Greater thanMa 5034.799
Ma 50Greater thanMa 10039.403
Ma 100Greater thanMa 20042.948
OpenGreater thanClose35.430
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Harrow Health Inc

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. Further, the company has collaboration with Asembia to enhance provider and patient experience through nationwide digital services and hub support for harrow's branded eyecare products. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.

Fundamental data was last updated by Penke on 2025-01-16 22:05:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Harrow earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -8.6% means that $-0.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harrow Health Inc:

  • The MRQ is -8.6%. The company is making a loss. -1
  • The TTM is -21.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-8.6%TTM-21.5%+13.0%
TTM-21.5%YOY-11.4%-10.1%
TTM-21.5%5Y-15.7%-5.8%
5Y-15.7%10Y-48.9%+33.2%
4.3.1.2. Return on Assets

Shows how efficient Harrow is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.2% Return on Assets means that Harrow generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harrow Health Inc:

  • The MRQ is -1.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM-2.7%+1.5%
TTM-2.7%YOY-1.5%-1.3%
TTM-2.7%5Y-2.8%+0.1%
5Y-2.8%10Y-7.9%+5.0%
4.3.1.3. Return on Equity

Shows how efficient Harrow is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • -7.3% Return on Equity means Harrow generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harrow Health Inc:

  • The MRQ is -7.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.3%TTM-13.5%+6.2%
TTM-13.5%YOY-13.0%-0.5%
TTM-13.5%5Y-46.6%+33.1%
5Y-46.6%10Y-153.3%+106.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Harrow Health Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Harrow is operating .

  • Measures how much profit Harrow makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 2.7% means the company generated $0.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harrow Health Inc:

  • The MRQ is 2.7%. The company is operating less efficient.
  • The TTM is -8.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ2.7%TTM-8.5%+11.2%
TTM-8.5%YOY-4.1%-4.4%
TTM-8.5%5Y-7.3%-1.2%
5Y-7.3%10Y-45.3%+38.0%
4.3.2.2. Operating Ratio

Measures how efficient Harrow is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are $0.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Harrow Health Inc:

  • The MRQ is 0.973. The company is less efficient in keeping operating costs low.
  • The TTM is 1.066. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.973TTM1.066-0.093
TTM1.066YOY0.980+0.086
TTM1.0665Y0.996+0.070
5Y0.99610Y1.425-0.429
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Harrow Health Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Harrow is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.55 means the company has $1.55 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Harrow Health Inc:

  • The MRQ is 1.548. The company is able to pay all its short-term debts. +1
  • The TTM is 2.491. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.548TTM2.491-0.943
TTM2.491YOY4.420-1.930
TTM2.4915Y4.367-1.876
5Y4.36710Y3.333+1.034
4.4.3.2. Quick Ratio

Measures if Harrow is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.33 means the company can pay off $1.33 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harrow Health Inc:

  • The MRQ is 1.330. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.237. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.330TTM2.237-0.907
TTM2.237YOY3.743-1.506
TTM2.2375Y4.732-2.496
5Y4.73210Y3.540+1.192
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Harrow Health Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Harrow assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Harrow to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.84 means that Harrow assets are financed with 83.6% credit (debt) and the remaining percentage (100% - 83.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harrow Health Inc:

  • The MRQ is 0.836. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.805. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.836TTM0.805+0.031
TTM0.805YOY0.842-0.037
TTM0.8055Y0.773+0.032
5Y0.77310Y0.740+0.033
4.5.4.2. Debt to Equity Ratio

Measures if Harrow is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 507.0% means that company has $5.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harrow Health Inc:

  • The MRQ is 5.070. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.167. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ5.070TTM4.167+0.903
TTM4.167YOY6.458-2.291
TTM4.1675Y8.671-4.505
5Y8.67110Y12.178-3.507
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Harrow generates.

  • Above 15 is considered overpriced but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -95.09 means the investor is paying $-95.09 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harrow Health Inc:

  • The EOD is -70.770. Based on the earnings, the company is expensive. -2
  • The MRQ is -95.093. Based on the earnings, the company is expensive. -2
  • The TTM is -35.854. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-70.770MRQ-95.093+24.323
MRQ-95.093TTM-35.854-59.239
TTM-35.854YOY6.745-42.599
TTM-35.8545Y-2.645-33.209
5Y-2.64510Y-5.166+2.521
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Harrow Health Inc:

  • The EOD is 123.002. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 165.277. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 23.290. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD123.002MRQ165.277-42.275
MRQ165.277TTM23.290+141.987
TTM23.290YOY7.569+15.721
TTM23.2905Y7.564+15.726
5Y7.56410Y-8.161+15.725
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Harrow is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Harrow Health Inc:

  • The EOD is 20.732. Based on the equity, the company is expensive. -2
  • The MRQ is 27.857. Based on the equity, the company is expensive. -2
  • The TTM is 13.558. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD20.732MRQ27.857-7.125
MRQ27.857TTM13.558+14.299
TTM13.558YOY23.024-9.466
TTM13.5585Y41.877-28.319
5Y41.87710Y47.671-5.794
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Harrow Health Inc.

4.8.1. Institutions holding Harrow Health Inc

Institutions are holding 59.06% of the shares of Harrow Health Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Opaleye Management Inc11.203229.9204399000000
2024-09-30BlackRock Inc6.46510.002223025311540267.169
2024-09-30Private Capital Management, LLC6.075210.42692163681-551170-20.302
2024-09-30Vanguard Group Inc5.24190.00151866875261651.4215
2024-09-30State Street Corp2.05240.0013730973155542.1741
2024-09-30Geode Capital Management, LLC2.02930.002672273039600.5509
2024-09-30D. E. Shaw & Co LP1.74880.0246228186228180
2024-09-30BRAIDWELL LP1.23440.560343963814245047.9326
2024-09-30Stifel Financial Corp1.14350.0192407264-135583-24.9763
2024-09-30Morgan Stanley - Brokerage Accounts1.02740.0012365922220308151.2959
2024-09-30Royce & Associates, LP1.01170.1473360320-179580-33.2617
2024-09-30Nuveen Asset Management, LLC0.92360.0042328924-97019-22.7775
2024-09-30First Turn Management LLC0.9172.32473265823265820
2024-09-30Rice Hall James & Associates, LLC0.88410.76623148815901923.0667
2024-09-30Northern Trust Corp0.83340.002229681867822.3383
2024-09-30Renaissance Technologies Corp0.82490.0199293770-12438-4.0619
2024-09-30Charles Schwab Investment Management Inc0.70650.0022251629166602195.9401
2024-09-30JPMorgan Chase & Co0.66930.0008238367194480443.1381
2024-09-30VOLORIDGE INVESTMENT MANAGEMENT, LLC0.60570.03532157312157310
2024-09-30Gilder Gagnon Howe & CO LLC0.58830.11272095152095150
Total 46.185744.375116448969+1388202+8.4%

4.9.2. Funds holding Harrow Health Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-11-30Vanguard Total Stock Mkt Idx Inv2.74740.0022978489-17866-1.7931
2024-12-31iShares Russell 2000 ETF2.32070.0386826514-3175-0.3827
2024-09-30Private Capital Management Value Focus1.379513.355949131500
2024-11-30Vanguard Institutional Extnd Mkt Idx Tr1.2940.01594608481220.0265
2024-10-31Fidelity Small Cap Index0.87630.052331210913980.4499
2024-12-31iShares Russell 2000 Growth ETF0.78890.074628094800
2024-09-30Private Capital Value Equity0.634714.007122603300
2024-12-31State St Russell Sm/Mid Cp® Indx NL Cl C0.54780.0145195100-4100-2.0582
2024-11-30Fidelity Extended Market Index0.47310.0159168506-1111-0.655
2024-12-31Schwab US Small-Cap ETF™0.41860.027214908300
2024-11-30Vanguard Russell 2000 ETF0.40390.043414385245993.3026
2024-09-30Private Capital Management Value I0.393110.3096140000-86033-38.0621
2024-12-31SPDR® S&P Pharmaceuticals ETF0.38162.787713591635862.7099
2024-12-31Invesco Dorsey Wright SmallCap Momt ETF0.33840.40081205332180.1812
2024-12-31State St Russell Sm Cap® Indx SL Cl I0.30830.038710980000
2024-09-30Kennedy Micro Cap0.29280.9572104263-1412-1.3362
2024-11-30Calamos Timpani Small Cap Growth I0.28250.95771006234557882.8013
2024-11-30Vanguard Health Care ETF0.27980.020399649-429-0.4287
2024-09-30Royce Small-Cap Opportunity Invmt0.27040.351496303-40827-29.7725
2024-09-30Royce Smaller-Companies Growth Svc0.22941.988781700-35000-29.9914
Total 14.661245.45975221584-134452-2.6%

5.3. Insider Transactions

Insiders are holding 13.486% of the shares of Harrow Health Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-25Opaleye Management Inc.BUY200009.97
2024-04-23Opaleye Management Inc.BUY1171510.29
2024-04-19Opaleye Management Inc.BUY2940010.56
2024-03-28Opaleye Management Inc.BUY5000012.82
2024-03-22Mark L BaumBUY900011.59
2024-03-20Opaleye Management Inc.BUY506009.65
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
EBIT  -1,429-3,130-4,559-3,591-8,1507,803-3471,6721,325



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets351,539
Total Liabilities293,918
Total Stockholder Equity57,976
 As reported
Total Liabilities 293,918
Total Stockholder Equity+ 57,976
Total Assets = 351,539

Assets

Total Assets351,539
Total Current Assets147,062
Long-term Assets204,477
Total Current Assets
Cash And Cash Equivalents 72,601
Net Receivables 53,734
Inventory 10,156
Other Current Assets 10,343
Total Current Assets  (as reported)147,062
Total Current Assets  (calculated)146,834
+/- 228
Long-term Assets
Property Plant Equipment 13,004
Goodwill 332
Intangible Assets 189,272
Long-term Assets Other 1,869
Long-term Assets  (as reported)204,477
Long-term Assets  (calculated)204,477
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities95,005
Long-term Liabilities198,913
Total Stockholder Equity57,976
Total Current Liabilities
Short-term Debt 1,014
Accounts payable 25,277
Other Current Liabilities 93,854
Total Current Liabilities  (as reported)95,005
Total Current Liabilities  (calculated)120,145
+/- 25,140
Long-term Liabilities
Long term Debt 186,057
Capital Lease Obligations 10,007
Long-term Liabilities  (as reported)198,913
Long-term Liabilities  (calculated)196,064
+/- 2,849
Total Stockholder Equity
Common Stock35
Retained Earnings -158,162
Other Stockholders Equity 216,103
Total Stockholder Equity (as reported)57,976
Total Stockholder Equity (calculated)57,976
+/-0
Other
Capital Stock35
Cash and Short Term Investments 72,601
Common Stock Shares Outstanding 35,702
Current Deferred Revenue137
Liabilities and Stockholders Equity 351,539
Net Debt 123,463
Net Invested Capital 244,033
Net Working Capital 52,057
Property Plant and Equipment Gross 24,024
Short Long Term Debt Total 196,064



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-30
> Total Assets 
28
28
27
27
25
5,009
4,241
3,744
7,182
5,989
5,336
4,355
2,975
2,125
1,672
1,018
1,242
579
352
133
76
77
352
225
7,895
11,464
10,706
19,247
18,376
17,403
15,761
14,452
13,879
12,408
10,242
9,375
16,854
15,021
14,131
25,306
22,049
21,517
27,247
25,879
27,596
26,211
23,917
21,199
26,328
28,289
49,451
66,510
65,157
54,698
59,085
46,893
49,454
59,470
57,474
56,252
106,966
102,801
98,329
97,595
98,062
98,992
157,023
217,498
223,989
286,065
311,755
295,068
306,630
351,539
351,539306,630295,068311,755286,065223,989217,498157,02398,99298,06297,59598,329102,801106,96656,25257,47459,47049,45446,89359,08554,69865,15766,51049,45128,28926,32821,19923,91726,21127,59625,87927,24721,51722,04925,30614,13115,02116,8549,37510,24212,40813,87914,45215,76117,40318,37619,24710,70611,4647,89522535277761333525791,2421,0181,6722,1252,9754,3555,3365,9897,1823,7444,2415,0092527272828
   > Total Current Assets 
28
28
27
27
25
5,009
4,241
3,744
7,179
5,986
5,333
4,353
2,973
2,124
1,671
1,017
1,241
579
352
133
76
77
352
210
7,881
11,451
10,693
19,029
18,361
17,384
15,734
14,418
12,830
11,269
9,056
4,608
12,009
9,365
5,873
14,926
9,443
8,950
14,753
13,601
10,359
10,104
8,806
7,394
8,728
11,684
32,843
38,505
38,119
32,374
36,767
25,808
30,369
40,977
40,131
40,636
93,474
91,126
60,662
62,315
64,703
64,074
118,260
51,687
60,296
110,278
139,073
124,990
139,390
147,062
147,062139,390124,990139,073110,27860,29651,687118,26064,07464,70362,31560,66291,12693,47440,63640,13140,97730,36925,80836,76732,37438,11938,50532,84311,6848,7287,3948,80610,10410,35913,60114,7538,9509,44314,9265,8739,36512,0094,6089,05611,26912,83014,41815,73417,38418,36119,02910,69311,4517,88121035277761333525791,2411,0171,6712,1242,9734,3535,3335,9867,1793,7444,2415,0092527272828
       Cash And Cash Equivalents 
28
28
27
27
17
4,298
3,706
3,408
6,711
5,776
5,111
4,193
2,902
1,999
1,590
952
1,043
467
291
71
6
2
291
147
7,717
10,991
10,036
19,029
17,970
16,828
15,579
14,201
12,102
10,364
8,211
2,898
10,051
6,556
2,685
11,821
5,441
2,362
8,853
7,396
4,165
3,867
4,019
2,692
4,170
6,315
6,638
4,265
3,993
3,431
4,749
3,924
3,902
5,527
4,101
6,304
72,651
57,656
42,167
41,948
46,438
44,959
96,270
19,248
22,754
65,610
74,085
68,538
70,968
72,601
72,60170,96868,53874,08565,61022,75419,24896,27044,95946,43841,94842,16757,65672,6516,3044,1015,5273,9023,9244,7493,4313,9934,2656,6386,3154,1702,6924,0193,8674,1657,3968,8532,3625,44111,8212,6856,55610,0512,8988,21110,36412,10214,20115,57916,82817,97019,02910,03610,9917,71714729126712914671,0439521,5901,9992,9024,1935,1115,7766,7113,4083,7064,2981727272828
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
50
50
50
50
150
150
150
150
150
150
150
150
150
450
200
200
200
200
200
200
125
125
21,420
28,000
27,650
22,120
25,200
14,350
19,075
27,650
28,455
25,620
12,209
9,989
8,503
8,642
5,193
4,162
5,589
7,631
6,917
8,265
8,681
7,433
1,453
0
01,4537,4338,6818,2656,9177,6315,5894,1625,1938,6428,5039,98912,20925,62028,45527,65019,07514,35025,20022,12027,65028,00021,4201251252002002002002002004501501501501501501501501501505050505050000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43
81
68
81
436
579
701
840
943
1,922
3,074
2,921
3,036
2,856
2,720
1,624
1,611
1,583
1,781
1,964
2,921
2,987
3,516
2,731
2,783
2,803
3,010
2,662
3,253
3,710
17,802
4,518
6,065
6,864
6,882
6,388
12,309
18,258
18,696
36,489
29,188
52,216
53,734
53,73452,21629,18836,48918,69618,25812,3096,3886,8826,8646,0654,51817,8023,7103,2532,6623,0102,8032,7832,7313,5162,9872,9211,9641,7811,5831,6111,6242,7202,8563,0362,9213,0741,922943840701579436816881430000000000000000000000000000000
       Other Current Assets 
0
0
0
8
8
0
534
336
469
211
222
159
71
124
81
65
199
111
61
62
71
74
60
64
164
460
62
204
340
506
105
124
474
486
391
100
106
81
936
929
639
106
106
106
202
183
124
127
125
1,064
987
931
837
864
786
762
748
816
951
963
1,001
1,754
1,257
1,264
1,112
2,927
21,990
32,439
37,542
44,668
8,951
9,021
6,781
10,343
10,3436,7819,0218,95144,66837,54232,43921,9902,9271,1121,2641,2571,7541,0019639518167487627868648379319871,0641251271241832021061061066399299368110610039148647412410550634020462460164646074716261111199658112471159222211469336534088000
   > Long-term Assets 
0
0
0
0
0
0
534
0
3
3
2
2
2
2
1
1
1
1
0
0
0
0
0
14
14
13
13
218
16
20
27
34
1,049
1,139
1,186
4,767
4,845
5,656
8,258
10,379
12,606
12,566
12,494
12,278
17,237
16,107
15,111
13,805
17,600
16,605
16,608
28,005
27,038
22,324
22,318
21,085
19,085
18,493
17,343
15,616
13,492
11,675
37,667
35,280
33,359
34,918
37,168
165,811
163,693
175,787
172,682
170,078
167,240
204,477
204,477167,240170,078172,682175,787163,693165,81137,16834,91833,35935,28037,66711,67513,49215,61617,34318,49319,08521,08522,31822,32427,03828,00516,60816,60517,60013,80515,11116,10717,23712,27812,49412,56612,60610,3798,2585,6564,8454,7671,1861,1391,04934272016218131314140000011112222330534000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
3
3
2
2
2
2
1
1
1
1
0
0
0
0
0
14
14
13
13
13
16
20
27
34
76
179
243
479
601
1,067
2,657
4,814
7,053
7,346
7,295
7,103
6,567
6,419
6,215
6,008
5,966
6,061
6,375
12,437
12,015
11,141
11,934
11,578
11,252
11,718
11,252
10,851
9,684
9,451
9,076
9,815
10,652
10,979
10,999
10,922
10,789
10,601
12,444
12,376
10,058
13,004
13,00410,05812,37612,44410,60110,78910,92210,99910,97910,6529,8159,0769,4519,68410,85111,25211,71811,25211,57811,93411,14112,01512,4376,3756,0615,9666,0086,2156,4196,5677,1037,2957,3467,0534,8142,6571,0676014792431797634272016131313141400000111122223300000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
332
332
332
1,134
1,180
1,419
2,466
2,466
2,466
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
3323323323323323323323323323323323323323323323323323323323323322,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,4662,4662,4661,4191,1801,13433233233200000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,509
4,577
3,809
2,694
6,513
5,353
4,947
10,229
9,642
8,560
7,715
6,830
5,541
4,485
3,820
2,521
1,594
0
11,133
8,247
5,601
2,097
0
0
0
0
0
0
0
0
000000002,0975,6018,24711,13301,5942,5213,8204,4855,5416,8307,7158,5609,64210,2294,9475,3536,5132,6943,8094,5775,50900000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
642
628
611
3,154
3,064
3,170
3,135
3,099
3,087
2,993
2,972
2,948
2,934
2,884
2,860
2,876
2,894
2,964
3,059
3,112
3,154
2,291
2,337
2,345
1,960
1,958
1,939
1,912
1,882
1,892
17,126
16,886
16,774
21,510
25,837
154,269
150,148
164,854
162,044
159,389
156,850
189,272
189,272156,850159,389162,044164,854150,148154,26925,83721,51016,77416,88617,1261,8921,8821,9121,9391,9581,9602,3452,3372,2913,1543,1123,0592,9642,8942,8762,8602,8842,9342,9482,9722,9933,0873,0993,1353,1703,0643,15461162864200000000000000000000000000000000
       Other Assets 
0
0
0
0
6
0
-534
336
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
973
960
943
4,288
4,244
4,589
5,601
1
5,553
1
5,199
5,175
10,670
9,688
8,896
256
11,634
10,544
0
0
0
0
0
0
0
0
11
0
0
0
0
0
0
0
1,595
0
288
0
0
0
0
0
0000028801,5950000000110000000010,54411,6342568,8969,68810,6705,1755,19915,55315,6014,5894,2444,288943960973000000000000000000000000336-534060000
> Total Liabilities 
1
1
3
5
4
243
750
471
921
607
764
1,245
1,029
901
1,095
1,054
1,469
1,400
1,391
1,535
1,599
1,648
1,391
930
491
670
710
849
1,108
1,059
651
655
1,835
2,124
2,092
3,169
11,614
12,777
15,516
16,522
16,441
18,685
20,815
20,562
19,950
22,465
21,302
21,116
22,596
23,836
24,700
29,476
30,159
30,971
31,667
31,865
34,058
34,542
30,646
28,382
84,118
86,567
87,398
87,859
92,668
98,130
130,138
195,970
201,937
210,663
241,753
235,330
248,453
293,918
293,918248,453235,330241,753210,663201,937195,970130,13898,13092,66887,85987,39886,56784,11828,38230,64634,54234,05831,86531,66730,97130,15929,47624,70023,83622,59621,11621,30222,46519,95020,56220,81518,68516,44116,52215,51612,77711,6143,1692,0922,1241,8356556511,0591,1088497106704919301,3911,6481,5991,5351,3911,4001,4691,0541,0959011,0291,24576460792147175024345311
   > Total Current Liabilities 
1
1
3
5
4
243
750
471
921
607
764
1,245
1,029
901
1,095
1,054
452
363
335
461
1,599
1,648
335
930
491
670
710
849
1,108
1,059
651
655
1,342
1,577
1,560
2,236
2,667
3,742
5,374
5,670
5,325
5,780
9,905
11,795
5,517
6,053
5,774
5,904
8,159
10,368
11,901
11,210
9,856
11,428
12,284
13,224
13,083
13,782
10,799
10,074
8,144
10,477
9,722
9,182
12,922
18,371
18,632
17,708
23,011
19,029
49,344
41,753
53,551
95,005
95,00553,55141,75349,34419,02923,01117,70818,63218,37112,9229,1829,72210,4778,14410,07410,79913,78213,08313,22412,28411,4289,85611,21011,90110,3688,1595,9045,7746,0535,51711,7959,9055,7805,3255,6705,3743,7422,6672,2361,5601,5771,3426556511,0591,1088497106704919303351,6481,5994613353634521,0541,0959011,0291,24576460792147175024345311
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,093
1,112
1,093
609
0
0
0
345
0
0
0
0
6
24
24
27
27
27
21
15
8
434
4,431
6,678
526
562
598
906
1,666
2,612
3,249
3,616
1,113
1,508
2,408
3,187
4,081
4,336
4,486
3,264
493
396
280
453
633
703
723
744
764
785
806
795
1,534
1,014
1,0141,5347958067857647447237036334532803964933,2644,4864,3364,0813,1872,4081,5081,1133,6163,2492,6121,6669065985625266,6784,431434815212727272424600003450006091,0931,1121,09300000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53
270
992
1,729
2,529
2,552
247
1,007
1,772
2,546
3,422
3,750
3,898
2,659
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000002,6593,8983,7503,4222,5461,7721,0072472,5522,5291,729992270530000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
201
0
696
428
879
524
698
781
603
427
681
560
122
76
74
161
406
436
74
257
424
595
287
849
765
698
262
357
750
804
787
1,145
1,181
1,917
3,407
4,253
3,956
3,795
3,538
3,920
3,344
4,035
3,885
3,883
4,663
5,931
6,250
6,143
6,943
8,144
7,409
7,527
5,780
5,691
3,932
5,176
3,882
4,671
5,174
5,595
8,038
7,043
18,632
13,794
10,506
12,772
21,424
12,567
20,177
25,277
25,27720,17712,56721,42412,77210,50613,79418,6327,0438,0385,5955,1744,6713,8825,1763,9325,6915,7807,5277,4098,1446,9436,1436,2505,9314,6633,8833,8854,0353,3443,9203,5383,7953,9564,2533,4071,9171,1811,14578780475035726269876584928759542425774436406161747612256068142760378169852487942869602010000
       Other Current Liabilities 
1
1
3
5
42
0
54
44
41
84
66
464
425
474
414
494
329
287
261
300
100
100
181
674
68
75
423
-1
341
358
389
298
585
747
748
2,094
1,386
1,777
1,881
1,352
2,670
2,992
3,690
2,378
3,278
2,896
2,524
2,084
3,592
3,454
4,566
1,092
3,152
3,456
4,820
4,900
6,338
7,384
4,630
3,262
7,426
10,814
8,504
3,111
4,168
10,510
-836
3,103
11,609
5,319
27,039
28,279
31,592
93,854
93,85431,59228,27927,0395,31911,6093,103-83610,5104,1683,1118,50410,8147,4263,2624,6307,3846,3384,9004,8203,4563,1521,0924,5663,4543,5922,0842,5242,8963,2782,3783,6902,9922,6701,3521,8811,7771,3862,094748747585298389358341-1423756867418110010030026128732949441447442546466844144540425311
   > Long-term Liabilities 
0
0
3,075
4,950
201
42,128
696
428
879
524
698
781
603
427
681
560
1,018
1,037
0
0
0
0
1,055
257
424
595
287
504
766
700
262
357
493
546
532
933
8,947
9,035
10,142
10,852
11,116
12,905
10,910
8,767
14,433
16,412
15,528
15,212
14,437
13,468
12,799
18,266
20,303
19,543
19,383
18,641
20,975
20,760
19,847
18,308
75,974
76,090
77,676
78,677
79,746
79,759
111,506
178,262
178,926
191,634
192,409
193,577
194,902
198,913
198,913194,902193,577192,409191,634178,926178,262111,50679,75979,74678,67777,67676,09075,97418,30819,84720,76020,97518,64119,38319,54320,30318,26612,79913,46814,43715,21215,52816,41214,4338,76710,91012,90511,11610,85210,1429,0358,9479335325464933572627007665042875954242571,05500001,0371,01856068142760378169852487942869642,1282014,9503,07500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
25
19
12
8,069
8,218
8,337
9,099
9,413
11,169
9,255
7,192
12,886
14,760
14,728
14,412
13,637
12,668
11,999
11,383
13,498
12,865
12,219
11,605
14,127
13,160
12,378
10,996
71,265
71,457
71,654
71,847
72,042
72,239
104,174
168,850
169,712
0
0
0
0
0
00000169,712168,850104,17472,23972,04271,84771,65471,45771,26510,99612,37813,16014,12711,60512,21912,86513,49811,38311,99912,66813,63714,41214,72814,76012,8867,1929,25511,1699,4139,0998,3378,2188,0691219251000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55
0
0
0
0
0
0
0
0
0
0
0
0
0
483
522
513
921
878
817
888
887
887
972
1,745
667
667
800
800
800
810
800
800
800
800
800
800
800
800
800
800
800
0
0
0
0
0
0
0
0
2,275
0
0
0
0
0
000002,275000000008008008008008008008008008008008008108008008006676671,745972887887888817878921513522483000000000000055000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
403
355
306
1,305
1,253
1,203
1,151
988
908
880
852
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,950
0
0
0
0
0
0
0
00000001,950000000000000000000008528809089881,1511,2031,2531,30530635540300000000000000000000000000000000000
> Total Stockholder Equity
27
27
24
22
21
0
3,490
3,273
6,262
5,382
4,572
3,110
1,947
1,224
577
-36
-227
-820
0
0
-1,523
-1,571
-1,038
-706
7,404
10,794
9,996
18,398
17,269
16,345
15,111
13,796
12,044
10,284
8,150
6,206
5,240
2,244
-1,385
8,784
5,608
2,832
6,432
5,317
7,646
3,746
2,615
83
3,732
4,453
24,751
37,059
35,065
23,955
27,711
15,337
15,728
25,275
27,183
28,225
23,203
16,589
11,286
10,091
5,749
1,217
27,240
21,528
22,052
75,402
70,357
60,093
58,532
57,976
57,97658,53260,09370,35775,40222,05221,52827,2401,2175,74910,09111,28616,58923,20328,22527,18325,27515,72815,33727,71123,95535,06537,05924,7514,4533,732832,6153,7467,6465,3176,4322,8325,6088,784-1,3852,2445,2406,2068,15010,28412,04413,79615,11116,34517,26918,3989,99610,7947,404-706-1,038-1,571-1,52300-820-227-365771,2241,9473,1104,5725,3826,2623,2733,49002122242727
   Common Stock
2
2
2
2
2
0
14
14
16
15
16
16
16
16
16
16
16
16
16
16
16
16
16
11
30
34
7
9
9
9
9
9
9
9
9
9
10
10
10
13
13
13
19
20
20
20
21
21
21
23
24
25
25
25
26
26
26
26
26
26
27
27
27
27
27
27
30
30
30
35
35
35
35
35
353535353530303027272727272726262626262625252524232121212020201913131310101099999999973430111616161616161616161616161615161414022222
   Retained Earnings -158,162-153,942-147,469-133,904-124,756-120,365-116,136-109,493-110,548-104,084-97,845-95,407-87,989-79,661-77,183-77,400-78,549-87,187-86,950-74,043-76,700-65,231-62,853-74,211-92,341-89,827-92,349-88,836-86,065-80,373-81,857-76,851-70,749-66,899-62,260-57,764-52,640-48,688-44,958-41,865-39,120-36,668-34,073-31,747-29,865-27,788-25,570-24,104-22,651-21,405-19,900-17,467-18,149-18,064-17,899-17,467-17,041-16,294-15,806-14,936-14,160-13,231-12,003-10,382-9,429-8,614-7,350-7,078-5,558-60-59-57-54-54
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,525
16,562
16,805
19,183
28,780
33,412
34,094
43,959
45,047
46,201
46,849
47,860
48,703
49,395
50,006
51,155
53,918
54,874
56,369
71,031
72,494
73,568
83,264
87,154
87,999
89,791
91,430
92,411
93,538
96,771
98,938
99,887
100,271
100,630
101,728
102,261
102,889
103,798
104,557
105,382
102,837
104,551
106,666
107,909
109,806
111,738
137,058
137,989
142,742
0
0
0
0
0
00000142,742137,989137,058111,738109,806107,909106,666104,551102,837105,382104,557103,798102,889102,261101,728100,630100,27199,88798,93896,77193,53892,41191,43089,79187,99987,15483,26473,56872,49471,03156,36954,87453,91851,15550,00649,39548,70347,86046,84946,20145,04743,95934,09433,41228,78019,18316,80516,56216,52500000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
80
80
80
80
80
0
10,554
10,610
14,860
14,795
14,938
15,097
15,162
15,368
15,497
15,755
16,051
16,204
0
0
0
0
16,413
19,183
28,780
33,412
34,094
43,959
45,047
46,201
46,849
47,860
48,703
49,395
50,006
51,155
53,918
54,874
56,369
71,031
72,494
73,568
83,264
87,154
87,999
89,791
91,430
92,411
93,538
96,771
98,938
99,887
100,271
100,630
101,728
102,261
102,889
103,798
104,557
105,382
102,837
104,551
106,666
107,909
109,806
111,738
136,703
137,634
142,387
200,123
204,226
207,995
212,439
216,103
216,103212,439207,995204,226200,123142,387137,634136,703111,738109,806107,909106,666104,551102,837105,382104,557103,798102,889102,261101,728100,630100,27199,88798,93896,77193,53892,41191,43089,79187,99987,15483,26473,56872,49471,03156,36954,87453,91851,15550,00649,39548,70347,86046,84946,20145,04743,95934,09433,41228,78019,18316,413000016,20416,05115,75515,49715,36815,16215,09714,93814,79514,86010,61010,55408080808080



5.4. Balance Sheets

Currency in USD. All numbers in thousands.